Hepcasia Administrator

15

Feb2017
A joint press release between I-MAK, DNP+ and MSF Access Campaign on challenges to patents (patent oppositions) was filed in India on key hep C drugs sofosbuvir, daclatasvir and velpatasvir. New Delhi/New York, 14 February 2017–Five new challenges against patents on crucial new medicines to treat ... Read More
February 15, 2017Hepcasia Administrator

21

Dec2016
December 21, 2016Hepcasia Administrator

21

Dec2016
December 21, 2016Hepcasia Administrator

28

Jun2016

15

Jun2016

03

May2016

18

Apr2016